HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.1
  1. Home
  2. /Compound

Enoxacin

HCID 3229
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
74011-58-8
Standard SMILES
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21
InChIKey
IDYZIJYBMGIQMJ-UHFFFAOYSA-N
Molecular formula
C15H17FN4O3
Average molar mass
320.32 g/mol
Monoisotopic mass
320.12846862

Overview

Enoxacin is a 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea. It has a role as an antibacterial drug and a DNA synthesis inhibitor. It is a monocarboxylic acid, an amino acid, a N-arylpiperazine, a 1,8-naphthyridine derivative, a quinolone antibiotic and a fluoroquinolone antibiotic.

Names & identifiers

Preferred name
Enoxacin
IUPAC
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
English name
Enoxacin
Molecular formula
C15H17FN4O3
Molecular weight
320.32

Names & synonyms

enoxacin74011-58-8PenetrexEnoxacine1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acidFlumarkComprecinEnoxacinoAT-2266EnoxacinumCI-9191-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
Show more names
1-ETHYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-[1-PIPERAZINYL]-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACIDENXci919enoramAbenoxEnoxenEnoxorHumark
PD 1077791-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acidPD-107779CI 919DTXSID5022984NSC-629661NSC-758416CHEBI:157175

Database identifiers

CAS
74011-58-8
PubChem CID
3229

Properties

Computed structural propertiesFilling in

XLogP
-0.2
Topological polar surface area
85.8 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
8
Rotatable bonds
3
Heavy atoms
23
Formal charge
0
Complexity
521

Experimental & physicochemical properties

Drugs · 4 items

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

LogP2.3
Solubility1.09e+00 g/L
Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Quinolones; Fluoroquinolones

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point · 2 items

220-224 °C

220 - 224 °C

Physical DescriptionSolid
Collision Cross Section · 2 items

184.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

185 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS ClassificationNot Classified

Hazard information

Hazard Classes and CategoriesNot Classified

Toxicology

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
2
rtecs
QN2800000
hs_code
29335995
Toxicity
LD50 in male, female mice, male, female rats (mg/kg): 327, 391, 236, 294 i.v.; 1237, 1320, >2000, >2000 s.c.; all >5000 orally (Senda)
risk_code
36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
safety_code
26-36/37
Hazard statements
H302-H315-H320-H335
Precautionary statements
P261-P280-P301+P312-P302+P352-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 2 items

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein BindingEnoxacin is approximately 40% bound to plasma proteins in healthy subjects and is approximately 14% bound to plasma proteins in patients with impaired renal function.
Pharmacodynamics · 1 item

Enoxacin is a quinolone/fluoroquinolone antibiotic. Enoxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Enoxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. Enoxacin may be active against pathogens resistant to drugs that act by different mechanisms.

Mechanism of ActionEnoxacin exerts its bactericidal action via the inhibition of the essential bacterial enzyme DNA gyrase (DNA Topoisomerase II).
Biological Half-LifePlasma half-life is 3 to 6 hours.
Metabolism/MetabolitesHepatic. Some isozymes of the cytochrome P-450 hepatic microsomal enzyme system are inhibited by enoxacin. After a single dose, greater than 40% was recovered in urine by 48 hours as unchanged drug.
MeSH Pharmacological Classification · 3 items

Substances that inhibit the growth or reproduction of BACTERIA.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2.

Absorption, Distribution and ExcretionRapidly absorbed following oral administration, with an absolute oral bioavailability of approximately 90%.

Related reactions

7 records
New reaction record
HRID 223155 reaction equation
HRID 223155As reactantuspto-grants-1982_10
HRID 325612 reaction equation
HRID 325612As productuspto-grants-1984_04
HRID 325614 reaction equation
HRID 325614As reactantuspto-grants-1984_04
HRID 373327 reaction equation
HRID 373327As productuspto-grants-1992_11
HRID 467280 reaction equation
HRID 467280As productuspto-grants-1992_10
HRID 1215155 reaction equation
HRID 1215155As reactantTraining data from https://doi.org/10.1039/C8SC04228D (5/10)
HRID 2198810 reaction equation
HRID 2198810As reactantuspto-grants-1982_11

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
DTXSID
DTXSID5022984
ChEMBL
CHEMBL826
ChEBI
CHEBI:157175
UNII
325OGW249P
EC Number
961-175-5
Nikkaji
J20.568K

Physicochemical properties

Melting point
220 · 220-224 C
Boiling point
569.9 · 569.9±50.0 °C(Predicted)
Density
1.2931 · 1.2931 (estimate)
storage temp.
2 · 2-8°C
solubility
DMSO (Slightly), Methanol (Slightly)
pka
6.04 · 6.04±0.70(Predicted)
form
Solid
color
Off-White to Pale Yellow
Water Solubility
50 mg/ml · 50 mg/ml in 1 M NaOHSlightly soluble in sodium hydroxide, dimethyl sulfoxide, chloroform and methanol. Insoluble in water.
InChI
InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23)
InChIKey
IDYZIJYBMGIQMJ-UHFFFAOYSA-N
SMILES
N1(CC)C2C(=CC(F)=C(N3CCNCC3)N=2)C(=O)C(C(O)=O)=C1
CAS DataBase Reference
74011 · 74011-58-8(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
325 OGW249P · 325OGW249P
ATC code
1 MA04 · J01MA04
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H320-H335
Precautionary statements
261 · P261-P280-P301+P312-P302+P352-P305+P351+P338
Hazard Codes
Xi
Risk Statements
36 · 36/37/38
Safety Statements
26 · 26-36/37
WGK Germany
2 · 2
RTECS
2800000 · QN2800000
HS Code
29335995 · 29335995
Toxicity
50 in · LD50 in male, female mice, male, female rats (mg/kg): 327, 391, 236, 294 i.v.; 1237, 1320, >2000, >2000 s.c.; all >5000 orally (Senda)
Cellular LocationsCytoplasm

Uses & manufacturing

UsesUse (kg; approx.) in Germany (2009): >100
Applications · 5 items

DescriptionEnoxacin is a broad spectrum, quinolone-class, antibacterial agent closely related structurally to nalidixic acid. The serum half-life (6.2 hrs.) and urinary recovery (70%) are considerably greater than for other newer agents of this class, such as norfloxacin (10) and earlier mentioned ciprofloxacin.

DescriptionEnoxacin is a fluoroquinolone antibiotic. It is active against clinical isolates of a variety of Gram-positive and Gram-negative bacteria, including S. aureus, E. coli, K. pneumoniae, P. aeruginosa, and S. marcescens (MIC50s = 1, 0.12, 0.25, 0.5, and 1 mg/L, respectively). Enoxacin inhibits S. aureus DNA gyrase supercoiling activity and topoisomerase IV DNA decatenation (IC50s = 126 and 26.5 μg/ml, respectively). It increases survival in mouse models of systemic S. aureus, E. coli, K. pneumoniae, P. aeruginosa, and S. marcescens infection with ED50 values of 15.1, 2.2, 4.1, 120.3, and 7.6 mg/kg, respectively. Enoxacin (4 and 8 mg/kg per day) also reduces tumor growth in a 143B human osteosarcoma mouse xenograft model. Formulations containing enoxacin have previously been used in the treatment of urinary tract infections and gonorrhea.

UsesA fluororquinolone antibacterial used to treat urinary tract infections and gonorrhea.

UsesA flurorquinolone antibacterial used to treat urinary tract infections and gonorrhea.

UsesEnoxacin is an antibacterial agent used in the treatment of gastro enteritis including infectious diarrhea, respiratory tract infections, gonorrhea and urinary tract infections. It is a bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Upstream & downstream products

Upstream raw materials

(3alpha)-3-chloro-Cholest-4-eneNicotinamideEthyl propionateTolueneChloroformAcetyl piperazineChloranilDiethyl malonateEthyl N-piperazinecarboxylate2,6-Dichloro-3-nitropyridineFluoroboric acid2-BromoethanolMethanesulfonic acidPalladium hydroxideDiethyl ethoxymethylenemalonateAcetic anhydrideIsoamyl nitrite
Additional notes · 1 item

DefinitionChEBI: A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 p sition. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.